2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide

C162H226F3N19O12 — CID 158670281

IUPAC2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide
SMILESCC(C)C[C@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.CC(C)[C@@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.Cc1ccc(CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccc3ccccc23)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2ccccc2C(F)(F)F)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccnc2)CC1
InChIInChI=1S/C29H37N3O2.C29H43N3O2.C28H41N3O2.C26H34F3N3O2.C26H37N3O2.C24H34N4O2/c33-27(18-29-15-21-12-22(16-29)14-23(13-21)17-29)30-19-28(34)32-10-8-31(9-11-32)20-25-6-3-5-24-4-1-2-7-26(24)25;1-21(2)12-26(28(34)32-10-8-31(9-11-32)20-22-6-4-3-5-7-22)30-27(33)19-29-16-23-13-24(17-29)15-25(14-23)18-29;1-20(2)26(27(33)31-10-8-30(9-11-31)19-21-6-4-3-5-7-21)29-25(32)18-28-15-22-12-23(16-28)14-24(13-22)17-28;27-26(28,29)22-4-2-1-3-21(22)17-31-5-7-32(8-6-31)24(34)16-30-23(33)15-25-12-18-9-19(13-25)11-20(10-18)14-25;1-19-2-4-20(5-3-19)18-28-6-8-29(9-7-28)25(31)17-27-24(30)16-26-13-21-10-22(14-26)12-23(11-21)15-26;29-22(14-24-11-19-8-20(12-24)10-21(9-19)13-24)26-16-23(30)28-6-4-27(5-7-28)17-18-2-1-3-25-15-18/h1-7,21-23H,8-20H2,(H,30,33);3-7,21,23-26H,8-20H2,1-2H3,(H,30,33);3-7,20,22-24,26H,8-19H2,1-2H3,(H,29,32);1-4,18-20H,5-17H2,(H,30,33);2-5,21-23H,6-18H2,1H3,(H,27,30);1-3,15,19-21H,4-14,16-17H2,(H,26,29)/t;23?,24?,25?,26-,29?;22?,23?,24?,26-,28?;;;/m.01.../s1
InChIKeyIDWDNUXCDFFQRM-VOMGHKOXSA-N
MW2688.70 g/mol
LogP22.64
Rot. Bonds39

About 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide

2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide (PubChem CID 158670281) has the molecular formula C162H226F3N19O12 and a molecular weight of 2688.70 g/mol. Its IUPAC name is 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide.

Molecular Properties

Compound Name2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide
PubChem CID158670281
Molecular FormulaC162H226F3N19O12
Molecular Weight2688.70 g/mol
Exact Mass2686.76
IUPAC Name2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide
SMILESCC(C)C[C@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.CC(C)[C@@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.Cc1ccc(CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccc3ccccc23)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2ccccc2C(F)(F)F)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccnc2)CC1
InChIInChI=1S/C29H37N3O2.C29H43N3O2.C28H41N3O2.C26H34F3N3O2.C26H37N3O2.C24H34N4O2/c33-27(18-29-15-21-12-22(16-29)14-23(13-21)17-29)30-19-28(34)32-10-8-31(9-11-32)20-25-6-3-5-24-4-1-2-7-26(24)25;1-21(2)12-26(28(34)32-10-8-31(9-11-32)20-22-6-4-3-5-7-22)30-27(33)19-29-16-23-13-24(17-29)15-25(14-23)18-29;1-20(2)26(27(33)31-10-8-30(9-11-31)19-21-6-4-3-5-7-21)29-25(32)18-28-15-22-12-23(16-28)14-24(13-22)17-28;27-26(28,29)22-4-2-1-3-21(22)17-31-5-7-32(8-6-31)24(34)16-30-23(33)15-25-12-18-9-19(13-25)11-20(10-18)14-25;1-19-2-4-20(5-3-19)18-28-6-8-29(9-7-28)25(31)17-27-24(30)16-26-13-21-10-22(14-26)12-23(11-21)15-26;29-22(14-24-11-19-8-20(12-24)10-21(9-19)13-24)26-16-23(30)28-6-4-27(5-7-28)17-18-2-1-3-25-15-18/h1-7,21-23H,8-20H2,(H,30,33);3-7,21,23-26H,8-20H2,1-2H3,(H,30,33);3-7,20,22-24,26H,8-19H2,1-2H3,(H,29,32);1-4,18-20H,5-17H2,(H,30,33);2-5,21-23H,6-18H2,1H3,(H,27,30);1-3,15,19-21H,4-14,16-17H2,(H,26,29)/t;23?,24?,25?,26-,29?;22?,23?,24?,26-,28?;;;/m.01.../s1
InChIKeyIDWDNUXCDFFQRM-VOMGHKOXSA-N
XLogP22.64
TPSA328.79 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds39
Heavy Atoms196
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002688.70
LogP ≤ 522.64
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Analyze 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide?
The IUPAC name of 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide (CID 158670281) is 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide.
What is the SMILES notation for 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide?
The canonical SMILES for 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide is CC(C)C[C@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.CC(C)[C@@H](NC(=O)CC12CC3CC(CC(C3)C1)C2)C(=O)N1CCN(Cc2ccccc2)CC1.Cc1ccc(CN2CCN(C(=O)CNC(=O)CC34CC5CC(CC(C5)C3)C4)CC2)cc1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccc3ccccc23)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2ccccc2C(F)(F)F)CC1.O=C(CC12CC3CC(CC(C3)C1)C2)NCC(=O)N1CCN(Cc2cccnc2)CC1.
What is the InChIKey of 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide?
The InChIKey is IDWDNUXCDFFQRM-VOMGHKOXSA-N. The full InChI is InChI=1S/C29H37N3O2.C29H43N3O2.C28H41N3O2.C26H34F3N3O2.C26H37N3O2.C24H34N4O2/c33-27(18-29-15-21-12-22(16-29)14-23(13-21)17-29)30-19-28(34)32-10-8-31(9-11-32)20-25-6-3-5-24-4-1-2-7-26(24)25;1-21(2)12-26(28(34)32-10-8-31(9-11-32)20-22-6-4-3-5-7-22)30-27(33)19-29-16-23-13-24(17-29)15-25(14-23)18-29;1-20(2)26(27(33)31-10-8-30(9-11-31)19-21-6-4-3-5-7-21)29-25(32)18-28-15-22-12-23(16-28)14-24(13-22)17-28;27-26(28,29)22-4-2-1-3-21(22)17-31-5-7-32(8-6-31)24(34)16-30-23(33)15-25-12-18-9-19(13-25)11-20(10-18)14-25;1-19-2-4-20(5-3-19)18-28-6-8-29(9-7-28)25(31)17-27-24(30)16-26-13-21-10-22(14-26)12-23(11-21)15-26;29-22(14-24-11-19-8-20(12-24)10-21(9-19)13-24)26-16-23(30)28-6-4-27(5-7-28)17-18-2-1-3-25-15-18/h1-7,21-23H,8-20H2,(H,30,33);3-7,21,23-26H,8-20H2,1-2H3,(H,30,33);3-7,20,22-24,26H,8-19H2,1-2H3,(H,29,32);1-4,18-20H,5-17H2,(H,30,33);2-5,21-23H,6-18H2,1H3,(H,27,30);1-3,15,19-21H,4-14,16-17H2,(H,26,29)/t;23?,24?,25?,26-,29?;22?,23?,24?,26-,28?;;;/m.01.../s1.
What are the key properties of 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide?
2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide has a molecular weight of 2688.70 g/mol, XLogP of 22.64, 39 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(1-adamantyl)-N-[(2R)-1-(4-benzylpiperazin-1-yl)-3-methyl-1-oxobutan-2-yl]acetamide;2-(1-adamantyl)-N-[(2S)-1-(4-benzylpiperazin-1-yl)-4-methyl-1-oxopentan-2-yl]acetamide;2-(1-adamantyl)-N-[2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-2-oxoethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-(pyridin-3-ylmethyl)piperazin-1-yl]ethyl]acetamide;2-(1-adamantyl)-N-[2-oxo-2-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]ethyl]acetamide is sourced from PubChem (CID 158670281), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).